{"id":34224,"date":"2021-10-04T10:10:46","date_gmt":"2021-10-04T09:10:46","guid":{"rendered":"https:\/\/www.ceps.eu\/?p=34224"},"modified":"2021-10-04T10:10:46","modified_gmt":"2021-10-04T09:10:46","slug":"chinas-cptpp-membership-bid","status":"publish","type":"post","link":"https:\/\/www.ceps.eu\/chinas-cptpp-membership-bid\/","title":{"rendered":"China\u2019s CPTPP membership bid"},"content":{"rendered":"
As the Comprehensive and Progressive Trans-Pacific Partnership<\/a> (CPTPP) is a regional trade agreement with high thresholds for market liberalisation on regulatory issues, it came somewhat as a surprise that China formally applied<\/a> to join the 11 member pact on 16 September 2021.<\/p>\n Aside from the multitude of geopolitical complications looming large in the region, ranging from military to trade<\/a>, that could dampen the political support China needs to successfully join the agreement, the regulatory hurdles for China to overcome may be just as overwhelming \u2013 in no small part due to a number of Chinese ideological standpoints.<\/p>\n The likely economic cost with regard to China\u2019s state-owned enterprises (SOEs) is another important consideration. To be CPTPP-compatible, on top of other regulatory rules on SOEs, China must ditch its \u00a0practice for \u2018non-commercial assistance\u2019 granted to its SOEs, a root cause of market distortion. Chinese SOEs have the advantages of \u2018non-commercial assistance\u2019, meaning that solid commercial rationale is often only a secondary concern to them. Arguably, this allows them the flexibility and freedom to champion China\u2019s Belt and Road Initiative<\/a>.<\/p>\n A matter of trust<\/strong><\/p>\n Aside from having to toe the line of the CPTPP\u2019s black letter law, accession also requires the unanimous consent of the 11 existing CPTPP members (Article 30.4, CPTPP). As such, the geopolitical tensions in the Indo-Pacific region may not be in China\u2019s favour. Besides, even if some countries may be openly supportive of bringing China into the CPTPP framework (Malaysia<\/a> and Singapore<\/a> have already voiced support), trust is an invisible hurdle that China could easily trip over.<\/p>\n For example, a few of China\u2019s stances on data protection are at odds with some specific CPTPP Parties (e.g., Japan) and are also contrary to the CPTPP agreement itself. This is mainly because, to China, data is a commodity owned by the state. Admittedly, China\u2019s Personal Information Protection Law (PIPL) provides tighter personal information protection against processing activities conducted by the state, but then on \u2018data handling\u2019 the Chinese state does not seem to differentiate between personal data and other data forms (Article 3, Data Security Law). The resulting clash is that the CPTPP promotes the cross-border free flow of personal information whilst China imposes a data localisation requirement (Articles 31, 37, Cybersecurity Law; Article 38, PIPL ). Source code disclosure is another matter where the CPTPP and China hold competing positions, with the CPTPP opposing the disclosure.<\/p>\n Granted, the CPTPP encourages the development of mechanisms to promote compatibility between the different regimes on personal information protection (Article 14.8, CPTPP). But the underlying foundation for compatibility is trust, and this may be lacking between China and some CPTPP Parties. Therefore, it\u2019s uncertain how the fundamental differences on data protection could be amended when trust is hard to find.<\/p>\n A comparison with CAI<\/strong><\/p>\n China showed a lot flexibility during the negotiations on the EU-China Comprehensive Agreement on Investment<\/a> (CAI). With the momentum coming from the CAI negotiations, one may argue that China could have had a head start with the CPTPP negotiations. It seems that a \u2018due diligence\u2019 exercise has also been undertaken on the CPTPP by the relevant Chinese ministries, and \u2018doable\u2019 may be their conclusion. On certain chapters, such as those on the environment and labour rights, based on the CAI\u2019s provisional text, China\u2019s commitments in that treaty are CPTPP-plus<\/a>; as is the five-year patent extension for pharmaceutical products after marketing approval, just to give two examples. However, on SOEs, the commitments under CAI are more administrative in nature, whilst under the CPTPP, structural reform of the SOEs\u2019 operational model would be a prerequisite before they would be deemed CPTPP-compliant.<\/p>\n What this all means is that the thresholds for CPTPP negotiations are much higher for China, especially for its SOEs. In the first place, the CAI does not define what a SOE actually is, whilst the CPTPP clearly does (Article 17.1 CPTPP). Add in the detailed transparency requirements and the compliance burden for China is heavy. Consequently, scepticism on China\u2019s ability and willingness to deliver is only reasonable, however the CPTPP might alternatively be welcomed as a source of \u2018external pressure\u2019 for furthering reforms. This was the case when China joined the World Trade Organization (WTO) in 2001.<\/p>\n On top of this, the commitments pledged by China under the CAI have not yet been tested for delivery and the country\u2019s record on implementation is mixed at best. Under the CPTPP, China would be subject to its dispute settlement mechanism if it breaches CPTPP rules.<\/p>\n A few sacrifices too many?<\/strong><\/p>\n It is perhaps the prospect of China willingly forsaking \u2018non-commercial assistance\u2019 to its SOEs that results in the most genuine reactions of disbelief. The CPTPP prohibits \u2018non-commercial assistance\u2019, provided by its Parties, by their SOEs, and by its Parties to their SOEs, which may cause adverse effects on other Parties (Article 17.6, CPTPP). Such \u2018non-commercial assistance\u2019 summarises the modus<\/em> operandi<\/em> that China engages in and by some SOEs who only survive on favourable policies and easy financing. This gains them unfair advantages over private enterprises both domestically and overseas, causing, for example, excess capacity and market distortion<\/a>.<\/p>\n